Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Howard Lotsof
Introduction
Howard Lotsof discovered the anti-addictive effects of ibogaine in 1962. He was awarded a number of patents for the treatment of various chemical dependencies with ibogaine. The first of Lotsof’s patents, issued in 1985, was US Patent 4,499,096, Rapid Method for Interrupting the Narcotic Addiction Syndrome. The last patent in the series for the use of ibogaine to treat chemical dependence was US Patent 5,152,994, Rapid Method for Interrupting or Attenuating Poly-Drug Dependency Syndromes, awarded October 6, 1992.
Lotsof is active in promoting medical usage and further research of ibogaine and has an interest in chemical dependence patient advocacy including authoring the Ibogaine Patients’ Bill of Rights. Lotsof is a member of the Board of Directors of the National Alliance of Methadone Advocates and President of the Dora Weiner Foundation.
External links
- The Staten Island Project
- Ibogaine Patients’ Bill of Rights
- Ibogaine Dossier
- Development of Ibogaine to Treat Addiction
Template:Med-bio-stub Template:Hallucinogen-stub
de:Howard Lotsof no:Howard Lotsof sv:Howard Lotsof Template:WikiDoc Sources